Skip to main content
Clinical Trials/IRCT20180309039013N1
IRCT20180309039013N1
Recruiting
Phase 3

Comparative clinical study of the effectiveness of TauroLock™ solution with piperacillin-tazobactam as secondary prophylaxis of Port-Catheter infection in children with cancer

Shiraz University of Medical Sciences0 sites50 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Infection due to port catheter.
Sponsor
Shiraz University of Medical Sciences
Enrollment
50
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Having Port\-Catheter
  • Age between 0\-19
  • Having cancer

Exclusion Criteria

  • Critically ill patients
  • Patients with severe coagulation problems
  • No permission from child's parents

Outcomes

Primary Outcomes

Not specified

Similar Trials